– Compelling PAX-D results guided Alto’s acquisition of ALTO-207, designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – – Alto plans to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results